ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A December 10, 2014 By MassDevice Contributors Network Leave a Comment Zimmer proposes divestitures for EU regulators in Biomet deal December 4, 2014 by Brad Perriello
Zimmer proposes divestitures for EU regulators in Biomet deal December 4, 2014 By Brad Perriello Leave a Comment
EU, Zimmer agree to extend review of Biomet merger November 18, 2014 By Brad Perriello Leave a Comment
Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A November 5, 2014 By MassDevice Contributors Network Leave a Comment Medtronic unveils post-merger management structure October 30, 2014 by Val Kennedy
Zimmer posts Q3 earnings above expectations, narrows guidance October 23, 2014 By Brad Perriello Leave a Comment Zimmer‘s (NYSE:ZMH) 3rd-quarter earnings came in ahead of expectations on strong performances from its core knee and hip implant businesses.
JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A October 22, 2014 By MassDevice Contributors Network Leave a Comment JNJ continues to pay hefty integration charges on Synthes deal October 16, 2014 by Brian Johnson
JNJ continues to pay hefty integration charges on Synthes deal October 16, 2014 By Brian Johnson Leave a Comment
Peripherals transition team named in Medtronic, Covidien merger | The week in medtech M&A October 8, 2014 By MassDevice Contributors Network Leave a Comment Medtronic, Covidien name peripherals biz transition team October 1, 2014 by Alex Soule
EU to extend Zimmer, Biomet probe October 2, 2014 By MassDevice Contributors Network Leave a Comment UPDATED Oct. 2, 2013, with comment from Zimmer.
Zimmer adds Harvard spinout Etex Corp. October 2, 2014 By Alex Soule Leave a Comment Zimmer (NYSE:ZMH) said yesterday that it paid an unspecified amount for Etex Corp. and the bone biomaterials it’s developing in Cambridge, Mass.